期刊
ADVANCED DRUG DELIVERY REVIEWS
卷 177, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.addr.2021.113927
关键词
Neoantigen; Whole cancer cell vaccine; Immunogenic cell death; Liposome; Polymer; Microorganism; Delivery strategy; DC vaccine; Precise medicine
资金
- National Natural Science Foundation of China [U2001224, 32030062, 21821005]
- Strategic Priority Research Program of the Chinese Academy of Sciences [XDB29040303]
Personalized cancer vaccines have gained attention for their ability to overcome interindividual differences and show benefits for individual patients in the clinic. Various delivery vectors, including artificial materials, engineered microorganisms, cells and cell derivatives, have been studied to enhance the therapeutic performance of personalized cancer vaccines. These delivery vectors are utilized to improve antigen distribution and immune response strength, velocity, and duration through different delivery strategies.
In recent years, personalized cancer vaccines have gained increasing attention as emerging immunother-apies with the capability to overcome interindividual differences and show great benefits for individual patients in the clinic due to the highly tailored vaccine formulations. A large number of materials have been studied as delivery vectors to enhance the therapeutic performance of personalized cancer vaccines, including artificial materials, engineered microorganisms, cells and cell derivatives. These delivery vec-tors with distinct features are employed to change antigen biodistributions and to facilitate antigen uptake, processing and presentation, improving the strength, velocity, and duration of the immune response when delivered by different strategies. Here, we provide an overview of personalized cancer vaccine delivery vectors, describing their materials, physicochemical properties, delivery strategies and challenges for clinical transformation. (c) 2021 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据